MARIANNE TURNER: Open Payments
NPI 1336980234 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Lundbeck LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REZDIFFRA, REXULTI, Ozempic, Jornay PM, Xhance, Wegovy, JOURNAVX, QULIPTA.
Industry payments across NY — which companies pay providers there.
